We examined the cellular distribution of rat tryptase in rat skin, lung, small intestine, and peritoneal lavage cells by immunohistochemical techniques. Tryptase purified to apparent homogeneity from rat skin was used to generate a goat polydonal anti-rat tryptase antibody. Tryptase-containing cells were detected in lung, skin, and peritoneal lavage cells. Small intestine mucosa, on the other hand, showed few if any tryptase-positive cells. Sequential staining with Alcian blue and anti-tryptase antibody showed that tryptase is located only in mast cells. Sequential staining with safranin to identify the connective tissue type of mast cell and antitryptase antibody showed that tryptase resides only in this mast cell type. However, only a subpopulation of the safraninstained mast cells contained tryptase. In lung, 53% of the mast cells stained with safranin; 94% contained tryptase. In skin, 80% stained with s a f h ; only 6% contained tryptase. In peritoneal cells, more than 95% of the mast cells
Introduction
Different mast cell types have been described in rodent and human tissues (8) . In rats, mature mast cells are grouped under two major subsets, the connective tissue mast cells and the mucosal mast cells, on the basis of their dye-binding properties (7) . Alcian blue identifies both the mucosal mast cell type, which contains chondroitin sulfate proteoglycans, and the connective tissue mast cell type, which contains heparin and chondroitin sulfate proteoglycans. Safranin stains only the more highly sulfated heparin proteoglycan and thereby selectively stains the connective tissue mast cell type, but only a portion of these mast cells are safranin positive. For example, immature connective tissue mast cells stain with Alcian blue but poorly, if at all, with safranin (6). In skin, a substantial portion of the mast cells stain positively for Alcian blue and negatively for safranin, despite the fact that they contain heparin and have Supported by NIH grant AI27517. To whom correspondence should be addressed. were stained with safranin; 20% contained tryptase. In the bowel mucosa, where few cells are stained by safranin, no cells with tryptase were detected. The percentages of cells with chymase I that also contained tryptase were 80% and 84% for lung, 4% and 7% for skin, and 15% and 13% for peritoneal cells by respective simultaneous and sequential double labeling with anti-tryptase and anti-chymase I antibodies. This study suggests that the rat connective tissue type of mast cell is subdivided into two forms on the basis of the presence or absence of tryptase, whereas rat mucosal mast cells la& this enzyme. These results contrast with those in humans, in which tryptase is present in a l l mast cells, but are similar to mice, in which tryptase mRNA has been detected only in the connective tissue type. a protease composition reflective of the connective tissue type of mast cells (1) . Therefore, the dye-binding properties of mast cells have limitations as discriminating markers for the two mast cell types.
Recently, mast cell granule enzymes have been used successfully as markers in the identification of mast cell subsets. Monospecific and monoclonal antibodies against rat mast cell chymas? I and chymase I1 were used to distinguish the connective tissue type of mast cell from the mucosal type of mast cell, respectively (9, 10, 12) . Anti-chymase I antibody identified connective tissue mast cells in skin, tongue, intestinal serosa and submucosa, and lung pleural membrane. Anti-chymase I1 antibody identified mucosal mast cells as the predominant type in mucosa of small intestine and stomach. Chymase 11-positive mast cells also were detected in other tissue locations, such as around bronchi and in thymus, liver, and submucosa of stomach.
In mouse, copies of cDNA for six chymases, two tryptases, and a carboxypeptidase have been identified (5, 11, 25) . They were named MMCP-I, 2, 3, 4, 5 , and 5' for the chymases and MMCP-6 for one of the tryptases. Enzymes MMCP-1 and 2 were localized to mucosal %1 %2 CHEN, IRANI, BRADFORD, CRAIG, NEWLANDS, MILLER, HUFF, SIMMONS, SCHWARTZ mast cells in mouse intestine (23,29) and proteins MMCP-3,4, 5, 5' and 6 to connective tissue mast cells from the mouse peritoneal cavity (27). A trypsin-like activity has been localized to connective tissue mast cells from the mouse peritoneal cavity (19). Analysis of mRNA shows that MMCP-1, 2, and 4 mRNAs are expressed in the mucosal mast cell type and that the "As for chymases MMCP-3, 4, 5, and tryptase MMCP-6 are in the connective tissue mast cell type (11,27).
In humans, mast cells have been classified into MCT and M C r types on the basis of their neutral protease contents (15J6). The MCT type contains only tryptase; the MCTC type contains tryptase, chymase, mast cell carboxypeptidase, and a cathepsin G-like protease (also with specificity for chymotrypsin-like substrates). On the basis of tissue distribution, the MCT type corresponds more closely to the rat mucosal mast cell type, whereas the M C x type corresponds more closely to the rat connective tissue mast cell type.
Rat tryptase has been purified to apparent homogeneity from skin and characterized (3,15,16), and from peritoneal mast cells (18,19). The partial amino acid sequence of rat tryptase (45%) (4) is highly homologous to human (21,22,30) and dog (31) tryptases. In the current study, rat tryptase is shown to be located only in a subpopulation of the safranin-positive, chymase I-positive mast cells of the connective tissue type.
Materials and Methods

Materials
Alcian blue 8GX, safranin 0, diaminobenzidine, 3-amino-9-ethylcarbazole, H202 (30%). and peroxidase-conjugated rabbit anti-goat IgG (Sigma; St Louis, MO), molecular weight standards (Pharmacia; Piscataway, NJ), and peroxidase-conjugated swine anti-goat IgG (Boehringer Mannheim; Indianapolis, IN) were obtained as indicated. Rabbit IgG anti-chymase I had been made specific for chymase I by adsorption with chymase I1 and affinitypurification with chymase I (10). Tryptase used for immunization and various immunochemical procedures was purified to homogeneity from rat skin as described (3). Lung together with skin and peritoneal cells were taken from two and six, respectively, normal Sprague-Dawley animals; bowel was taken 14 days after infection of two Lewis rats with Nippostmngylus bradien-si^ (3000 larvaelanimal) as described previously (2). to amplify numbers of mucosal mast cells in the intestine. Samples of lung, skin, and bowel were fixed in Carnoy's fluid (60% ethanol, 30% chloroform, 10% glacial acetic acid) for 24 hr and then were transferred to absolute ethanol. Tissues were embedded in paraffin. For the lung and bowel tissues, 4-pm sections were prepared and 5 pm for the skin. Rat peritoneal cells were collected by lavage with PBS and subjected to cytocentrifugation, 2 x lo4 viable cells per slide.
Development of Goat Anti-rat Skin Tryptase Antibody
Purified rat tryptase (60 pg) was emulsified in 0.6 ml of complete Freund's adjuvant and injected subcutaneously into a goat on Day 0. On Days 18, 39, and 52 the same amount of the tryptase was emulsified in incomplete Freund's adjuvant and injected into the same goat. Serum with a high anti-rat tryptase titer by ELISA was collected and used for purification of IgG. For the ELISA, microtiter wells (Falcon Probind; Becton Dickinson, Lincoln Park, NJ) were coated with rat tryptase (10 nglwell) in 0.01 M Tris, pH 8.5, 0.15 M NaCI, 0.05% NaN3 (1 hr, room temperature) and residual uncoated sites were blocked with 0.1% BSA in 0.01 M Tris (pH 8.5), 1 M NaCI, 0.05% NaN3 (blocking buffer) (1 hr, room temperature). Diluted immune or preimmune serum was added to the blocking buffer and incubated for 1 hr at room temperature. After washing the wells with the blocking buffer, a 1:5000 dilution of alkaline phosphatase-conjugated swine anti-goat IgG was added and left to incubate for 1 hr. Then the wells were washed and residual alkaline phosphatase was measured by cleavage of p-nitrophenyl phosphate, which yielded p-nitrophenol with an absorbance at 405 nm. Immune serum gave an optical density at a 1:lOOo dilution that was more than tenfold higher than the absorbance of pre-immune serum or of immune serum in the absence of solid-phase rat tryptase. The IgG fractions from goat immune and pre-immune sera were purified by ammonium sulfate precipitation (45 %) and chromatography on DEAE-Sephacel.
Western Blot
Protein separation and semi-dry blotting were performed on a PhastSystem (Pharmacia) as recommended by the manufacturer (File 221). Proteins were separated by electrophoresis in 12.5 9' 0 polyacrylamide gels containing SDS. Two identical gels were run under the same conditions. One gel was subjected to Coomassie blue staining. The other was blotted onto a nitrocellulose membrane with 2.5 mM Tris, 192 mM glycine, and 20% methanol, pH 8.3, as transfer buffer. The nitrocellulose membrane was blocked with 3% bovine serum albumin in TBS (10 mM Tris-HCI, pH 7.5, 150 mM NaCI) for 1 hr. The blocked membrane was washed three times with TBS before it was incubated overnight at room temperature with the primary antibody (5 pglml of the goat anti-rat tryptase in TBS containing 0.5% bovine serum albumin). Then the membrane was washed twice with TBS and incubated for 2 hr with the second antibody (1:lOoO dilution of peroxidaseconjugated swine anti-goat IgG). Finally, the membrane was rinsed three times with TBS and developed with 0.2 mglml of3-amino-9-ethylcarbazole (AEC) and 0.01% H202 in 5% N,N-dimethyl formamide, 0.1 M acetate, pH 5.2, until color developed.
Immunohistochemistry
Paraffin-embedded sections were dewaxed in three changes of xylene and rehydrated through 100%. 95%. 80%, 70%, and 50% ethanol. Cytospin slides of peritoneal cells were fixed in Carnoy's solution for 15 min at room temperature before the immunohistochemical stain. When immunoperoxidase was used, endogenous peroxidase was blocked by incubation of the tissue sections with 0.6% H202 in methanol for 30 min at room temperature before rehydration in ethanol.
Single Stains. For the histochemical identification of mast cells, tissue sections or cytospins were incubated with 0.5% Alcian blue, pH 1, for 30 min or with 0.1% safmin in 1% acetic acid for 5 min. Histochemical preparations were washed with PBS and mounted in 90% glycerol. For immunohistochemical identification ofchymase I-positive and uyptase-positive cells, tissue sections were blocked with normal swine serum, normal rabbit serum, or normal goat serum for 3 hr at room temperature corresponding to the source of the second antibody. Sections then were incubated with the goat anti-rat tryptase antibody ( 5 pglml) or rabbit anti-rat chymase I antibody (3.2 pglml) overnight at 4'C. After washing in TBS containing 0.05% Tween-20 (TTBS), the sections were incubated with a 1:50 dilution of peroxidase-conjugated or alkaline phosphatase-conjugated anti-goat or anti-rabbit IgG for 1 hr at room temperature. Samples were washed again in " B S . For peroxidase, staining was performed with AEC and H202 as described above for Western blotting or with diaminobenzidine (DAB) (0.5 mglml) in 0.05 M Tris-HCI, pH 7.6, and 0.01% H202. For alkaline phosphatase, staining was performed with 0.2 mglml of naphthol AS-MX phosphate, 0.24 mglml of levamisole, and 1 mglml of Fast Blue RR in 0.1 M Tris-HCI, pH 8.2. After a final wash in water, sections stained with AEC or with Fast Blue RR were mounted with 90% glycerol; those developed with DAB were dried and mounted with Permount. Double Stain. To distinguish mucosal mast cells and connective tissue mast cells in the same section by histochemistry, Alcian blue-stained cells were counterstained with safranin as described above for single staining.
To determine the portion of mast cells that were tryptase positive or chymase I positive, Alcian blue-stained cells were incubated with anti-tryptase or and-chymase I antibodies as above and visualized with the peroxidase/AEC technique. Blue cells became reddish brown if they were stained by one of the antibodies, and otherwise remained blue. To determine whether AIcian blue staining interfered with the subsequent anti-uyptase stain, the numbers of tryptase-positive cells in sections stained with anti-tryptase antibody alone were compared to adjacent sections stained first with Alcian blue. For example, in adjacent sections of lung the number of tryptasepositive cells without exposure to Alcian blue (120 f 24) was not different from the number observed when Alcian blue staining preceded that for tryptase (125 t 7 cells). Similar results were obtained for skin, bowel, and peritoneal cells. Thus, no interference of Alcian blue staining with subsequent staining for tryptase was found. Analogous experiments performed with Alcian blue and rabbit anti-chymase I antibody showed that Alcian blue staining did not interfere with subsequent staining for chymase I (data not shown).
To examine whether tryptase resided only in the safranin-positive connective tissue type of mast cells, cells stained directly with safranin were photographed, washed, and stained with anti-tryptase antibody using the peroxidaselDAB technique described above. Red safranin-positive cells were reduced to background after washing, and became brown ifthey were uyptase positive, making it possible to visualize the peroxidase stain with negligible interference from safranin. As above for sequential staining with AIcian blue and anti-tryptase antibody, no interference of safranin staining with subsequent detection of tryptase was found. In three adjacent sections of lung, 119 k 35 safranin-positive and 114 k 41 tryptase-positive mast cells were detected. In contrast, analogous experiments performed with safranin and rabbit anti-chymase I antibodies showed a marked interference of safranin staining with the subsequent detection of chymase I (data not shown).
Simultaneous Double Labeling with Anti-tryptase and Anti-chymase I Antibodies. Because not all mast cells stained with the anti-tryptase antibody, simultaneous double labeling was performed with anti-tryptase and anti-chymase I antibodies to determine the percentage of cells containing either both or only one of the proteases. Tissue sections were blocked with normal swine serum for 3 hr and then incubated with both goat anti-tryptase ( 5 pglml) and rabbit anti-chymase I (3.2 pg/ml) overnight at 4'C. After washing three times with TTBS, a 1:50 dilution of the alkaline phosphataseconjugated swine anti-goat antibody containing 0.1% normal rabbit serum (to block any swine antibody recognizing rabbit IgG) was incubated with the sections for 1 hr at room temperature. The tryptase-positive cells were stained blue by the addition of naphthol AS-MX and Fast Blue RR. The slides were mounted in 90% glycerol and photographed. Coverslips were floated off in water at 37°C. The sections were then incubated with a 1:50 dilution of peroxidase-conjugated goat anti-rabbit antibody for 1 hr. Chymase I-positive cells were stained brown in AEC. The same fields were photographed. Negative controls included goat anti-uyptase with goat anti-rabbit IgG, rabbit anti-chymase I with swine anti-goat I@, and a mouse IgGl monoclonal antibody (MPC-11) which has no known antigenic specificity with both secondary antibodies.
Sequential Double Labeling with Anti-tryptase and Anti-chymase I An-t&odies. Once it became clear that essentially all cells containing tryptase also contained chymase I, a sequential double stain was developed to show the uyptase-positive and tryptare-negative subsets of chymase I-positive cells in the same section. Tissue sections were blocked with normal swine serum and then incubated with goat anti-tryptase (5 pg/ml) overnight at 4'C.
After three washes in lTBS, a 1:50 dilution ofperoxidase-conjugated swine anti-goat antibody was added to the sections. After 1 hr at room temperature, the tryptase-positive cells were stained brown as described above. The sections were mounted in 90% glycerol and photographed. Rabbit antichymase I antibody (3.2 pglml) was then incubated with the sections overnight at 4'C. After a 1-hr incubation with a 1:50 dilution of the alkaline phosphatase-conjugated goat anti-rabbit antibody, the chymase I-positive cells were stained blue. remounted, and photographed.
Photomicroscopy was performed with a Z c i Ultraphot microscope (Carl ZeisS; Oberkochen, Germany) using Kodak Ektachrome 64T fh. Positively stained cells were counted at x 160 magnification under light microscopy. Assessment of tissue surface area was obtained with a Zeiss videoplan apparatus. In the lung sections, only the peribronchial and peribronchiolar areas were measured. In the bowel sections, more than a dozen randomly selected areas were measured and positive cells counted. Mast cell concentrations were determined as described previously (14):
where 10 pm was used as an estimate of the average mast cell diameter and 4 pm was the tissue thickness for lung and bowel; 5 pm was used for skin.
Results
Specr9city of Gout Anti-rat Tryptase Antibody
To examine the specificity of the anti-tryptase IgG, Western blots were performed (results not shown). Twenty micrograms of extracts from rat skin and 100 ng of purified tryptase were run individually and together per lane. Also examined were 20 pg of the crude extract from rat lung. Amounts of tryptase in these extracts were estimated based on the specific activity of the enzyme purified from skin and the enzymatic activity in each extract using benzoylarginine ethyl ester (3). In each case there was less than 1 n g of tryptase applied to the gel. The sensitivity of the Western blot technique for purified tryptase was approximately 50 ng; approximately 500 ng tryptase was needed for detection by Coomassie blue. Accordingly, tryptase was detected immunologically only when purified tryptase was added to an extract or assessed by itself. The results show a lack of binding to the many other proteins present in each tissue extract, indicating a high degree of specificity for tryptase.
Distribzltions of the Mast CeZZs and Tryptase-Positive Cells
The distributions of red safranin-positive and blue safranin-negative mast cells after staining with Alcian blue and safranin, and of tryptase-positive cells by immunohistochemistry, were determined in comparable sections of skin, bowel, and lung and in cytospin preparations of peritoneal cells. In lung, mast cells were detected primarily in peribronchial tissue, 53 % being safranin positive (Table l). Unlike human lung, few mast cells were detected in the alveolar wall. In skin, most of the mast cells were located in the dermis and in the deep fascia, in each case being 81% safranin positive. In the bowel mucosa from N. brasilensir-infected animals, safranin-negative mast cells, presumably of the mucosal type, were abundant, accounting for >99% of the mast cells. Mast cells obtained by peritoneal lavage accounted for 5-10% of the cells, and more than 95% were safranin positive. Tiyptase-containing cells also were assessed in lung, skin, bowel, and peritoneal cells using goat IgG anti-uyptase antibody. No staining was observed with pre-immune goat IgG as a negative control. Tryptase-containing cells were most abundant in lung, where they were distributed in a peribronchial location. Among peritoneal cells they accounted for only 1-2% ofthe cells. In skin, tryptase-positive cells were detected in the dermis and below the hypodermis, but at concentrations that appeared to be less than for mast cells detected histochemically. In bowel mucosa there were essentially no tryptase-positive cells.
Rat Syptase Is Localized in Mast Cells
To determine whether tryptase-containing cells were mast cells and only mast cells, sequential staining with Alcian blue and antitryptase antibody was performed. For example, in a section of rat lung, among three Alcian blue-stained mast cells (a fragment of one mast cell also is seen) ( Figure IA) , two stained positive for tryptase ( Figure 1B ). In these double-labeling experiments the concentration of mast cells in peribronchial tissue was about 15 x IO3 * 4 x lo3 cells/mm3; 63% * 8% contained tryptase (Eble 1).
In rat skin, two Alcian blue-positive mast cells are shown in Figure  IC , one of which stained positive for uyptase ( Figure 1D ). In general, tryptase-positive mast cells stained less intensely in skin than in lung. Tryptase-positive mast cells accounted for only 7 * 4% of the 574 * 87 mast cells/mm3 in the dermis (Tible 1). A cluster of seven mast cells obtained from the peritoneal lavage is shown in Figure 1E , three of which contain tryptase ( Figure IF) . The intensity of tryptase staining was comparable to mast cells in skin. Mast cells accounted for 8% of the total cells, 19% of which contained tryptase (Table 1 ). In rat bowel mucosa from N. brasiliensirinfected animals, essentially none ofthe mast cells (32,264 2 22,219 cellslmm3) (Eble 1) that stained blue ( Figure 1G ) showed detectable tryptase ( Figure 1H ). Bowel submucosa was not examined. The high standard deviation for the concentration of mast cells in the bowel reflects the uneven distribution of these mast cells in the cross-sections of the bowel. Of 591 tryptase-positive cells examined in lung, skin, and peritoneal lavage cells, all stained with Alcian blue, implicating mast cells as the major source of this enzyme among the cells and tissues examined.
Sequential staining with Alcian blue and anti-chymase I antibody showed that 60% of the Alcian blue cells in lung are chymase I positive. More than 85 % of the Alcian blue cells are chymase I positive in skin, 98 2 2% of the Alcian blue cells are chymase I positive among peritoneal cells, and none of the Alcian blue cells in bowel mucosa were chymase I positive.
Rat Syptase Resides in the Safranin-positive Cells.
To determine the distribution of tryptase-positive mast cells among safranin-positive and safranin-negative mast cells, sequential staining was performed, first with safranin and then with anti-rat tryptase.
The results revealed that all uyptase-positive cells were safranin positive, but not all safranin-positive cells contain tryptase. For lung, Figure 2A shows five safranin-positive mast cells, all of which except for one definitely contain tryptase ( Figure 2B ). In rat lung, more than 90% of the safranin-positive cells were tryptase positive ( Table 1) . By contrast, in skin, six safranin-positive mast cells are shown in Figure 2C , only one of which was tryptase positive (Figure 2D ). Only about 6% of the safranin-positive cells in skin contained tryptase (Table I) . Bowel mucosa lacked safranin-and antitryptase-stainable cells. In peritoneal cells, Figure 2E shows 15 safranin-positive mast cells (phase-contrast), only four of which contained detectable tryptase ( Figure 2F ). Tryptase-positive cells accounted for only 19% of the rat peritoneal connective tissue mast cells ( Table 1) .
Distribution of Ttyptase and Chymase I in Rat Mast Cells
Simultaneous double-labeling experiments were performed to determine whether tryptase-positive cells are also chymase I positive.
In lung, Figure 3A shows three blue tryptase-positive cells, all of Distribution of tryptase-positive mast cells among those of the safianin-negative and safranin-positive 69 mm2 for peribronchus, 39.9 mm2 for dermis, and 17.0 mm2 for bowel mucosa; a , number of which became dark brown ( Figure 3B) , indicating the co-localization of chymase I in these cells. Of the total number of mast cells containing tryptase, chymase I, or both, 77% contained both proteases, 4% contained only uyptase, and 19% contained only ch-I (Eble 2). Whether the small population of cells (4%) that stained for tryptase and not chymase I truly rdects negatively stained chymase I cells is not completely certain, because low levels of staining for chymase I may not produce sufficient brown staining to Overcome the blue stain from tryptase. In skin, Figure 3C shows a light blue tryptase-positive cell that became brown with the chymase I stain ( Figure 3D ). Among the mast cells containing tryptase and chymase I in skin, 96% contained only chymase I, 4% contained both proteases, and no cells containing only tryptase were detected (Table 2) . For peritoneal cells, Figure 3E (phase-contrast) shows one blue tryptase-positive cell that became brown with the chymase I stain ( Figure 3F , phasecontrast), and also shows seven chymase I-positive cells in which tryptase was not detected. Among the mast cells containing tryptase and chymase I in peritoneal lavage fluid, 15% contained both proteases, 85% contained chymase I alone, and none contained tryptase without chymase I (Table 2) .
To better ascertain the distribution of chymase I and tryptase in a single section, sequential double-labeling experiments were performed. With this technique, deposition of the reddish-brown peroxidase-based stain with the first primary antibody blocks subsequent staining of those cells with the second primary antibody linked to alkaline phosphatase. This same phenomenon has been observed previously for staining of human mast cells (13, 15) . In lung, Figure 4A shows two brown tryptase-positive cells. These cells remained brown, whereas two others stained blue with the antichymase antibody ( Figure 4B ). By sequential staining, tryptasepositive cells in lung accounted for 84 7% of the chymase I-positive cells (Table 3 ). In skin, a section is shown that contains one tryptase-positive cell ( Figure 4C ) and one chymase I positive, tryptase-negative cell ( Figure 4D ). Tryptase-positive cells in skin accounted for 7 f 1% of the chymase I-positive cells (Eble 3). In peritoneal cells, Figure 4E shows five nucleated tryptase-positive cells; subsequent staining with anti-chymase I antibody revealed an additional four nucleated chymase I-positive cells ( Figure 4F ). About 13 f 7% of the chymase I-positive cells in peritoneal lavage fluid were also tryptase positive (Eble 3).
Discussion
Although rat tryptase has been purified from skin (3) and peritoneal cells (18). its cellular localization has never been formally determined in this species. In the present study, a goat polyclonal IgG antibody preparation against tryptase purified to homogeneity from rat skin was used to determine the distribution of tryptase in rat skin, lung, bowel mucosa, and peritoneal cells. The antibody was produced in high titer, as determined by ELISA, and was specific, as determined by Western blotting with extracts from lung, skin, and peritoneal cells. Although the level of endogenous tryp- 
Ranges of the numbers of cells counted per section or slide. tase (approximately 0.003% of total protein) was too low for detection by this technique, exogenously added tryptase, but no other protein, was detected. By a variety of histochemical and immunohistochemical techniques, tryptase was localized exclusively in mast cells, but only in a subset of the connective tissue type of mast cell. Localization to mast cells was demonstrated by sequential staining with Alcian blue and anti-tryptase antibody. Only the blue mast cells were stained by the antibody. However, although the majority of mast cells in lung contained tryptase, most in skin, bowel, and peritoneal cells did not contain tryptase. Before examining the distribution of tryptase among safranin-negative (mucosal and a portion of the connective tissue mast cells) and safranin-positive (the remaining portion of the connective tissue mast cells) cells, the distributions of these two histochemical phenotypes were assessed by sequential staining with Alcian blue and safranin. This showed that lung tissue contained similar numbers of both mast cell phenotypes, skin and peritoneal mast cells were almost exclusively of the safranin-positive type, and those in the bowel mucosa were almost exclusively of the safranin-negative type. These distributions are similar to those previously reported (7, 10, 12) . Sequential staining with safranin and anti-tryptase antibody clarified in part the localization of tryptase. Safranin stains many but not all of the heparin-containing mast cells, and therefore marks some but not all of the connective tissue mast cells. Tryptase was present only in safranin-positive cells, but not in all safranin-positive cells. This varied from tissue to tissue; in lung 94% of the safranin-positive mast cells stained for tryptase, in peritoneal cells 20%, and in skin 6%. Thus, even though tryptase was purified from skin, the percentage of mast cells containing the enzyme in skin is markedly lower than in lung.
To confirm localization of tryptase to the connective tissue type of mast cells, double-labeling experiments were performed with anti-tryptase and anti-chymase I antibodies. Mast cell-specific proteases are precise markers of mast cells that distinguish mast cells from other cell types and mast cell subsets from one another (28). In rats, chymase I (also called rat mast cell protease I) and chymase I1 (also called rat mast cell protease 11) have been used to distinguish connective tissue mast cells from mucosal mast cells, respectively (20). Only in lung was there a suggestion that tryptase could reside in mast cells lacking chymase I. In this case 4016 of tryptasestained mast cells did not develop detectable staining for chymase I by the simultaneous labeling technique. We view this as an upper limit, because variations in staining intensity from one cell to the next in tissue sections may lead to a more intense tryptase stain followed by a less intense stain for chymase I, which, at the extreme, may not be detectable by this technique. Therefore, the existence ofa minor population ofuyptase-positive, chymase I-negatk cells in intestine is questionable. In lung, skin, and peritoneal cells all uyptasestained mast cells also contained chymase I. To more easily determine the distribution of tryptase among the connective tissue mast cells, sequential double labeling with anti-tryptase and then antichymase I antibodies was performed, such that tryptase-positive cells retained only the stain for tryptase (even though they also contained chymase I); those negative for tryptase stained for chymase I. The respective percentages of cells that contained tryptase by the sequential chymase I technique, the simultaneous chymase I technique, and the sequential safranin technique were similar: 84O16, 80%,and94% forlung; 7%,4%,and6% forskin; and 13%, 1596, and 20% for peritoneal cells. Therefore, rat tryptase is present in a subset of the connective tissue type of mast cell.
Our results for tryptase in rat tissues more closely parallel previously made observations in mouse than in human. In humans, all mast cells contain tryptase, whereas only a subset contains chymase, carboxypeptidase, and a cathepsin G-like protease (17) . In mice, cDNA molecules for at least five chymases, two tryptases, and one carboxypeptidase have been identified (26, 27) . Northern blots with tissue extracts enriched for mucosal and connective tissue mast cells suggest that mouse tryptase (MMCP-6), as for rat tryptase, is located in connective tissue mast cells (24), whereas chymases are distributed either in mucosal or connective tissue or in both mast cell types.
The finding that only a subpopulation of connective tissue mast cells contains tryptase in the rat indicates a greater degree of heterogeneity than anticipated. One possible explanation for this finding is that tryptase expression is permissible only in connective tissue mast cells but is regulated and inducible by environmental factors. An alternative explanation is that the antibodies used fail to detect a second form of tryptase that is more widely distributed among mast cells. However, this seems unlikely given the high degree of immunologic crossreactivity appreciated between rat chymases I and I1 in one case, and between recombinant human tryptase molecules in another case. Another alternative explanation is that the [tryptase+I chymaseI+)chymase 11-1, [tryptase-Ichymase I+\chymase 11-1, and [tryptase-lchymase I-Ichymase U+] mast cells represent three distinct subsets. Further studies will be needed to clardy what is related to lineage and what is related to environment.
